Abstract: A process for making a coated abrasive for diamond grinding wheels in which a clean synthetic diamond grit is moistened with an aqueous wetting agent solution, a metal mixture consisting of about 70 percent deoxidized copper, about 20 percent tin and about 10 percent titanium hydride is added to the moistened diamond grit, a highly refractive and abrasive ceramic is added to the diamond-metal mixture, the resulting composition is sintered in a furnace with an inert atmosphere, the sintered composition is allowed to cool and is then comminuted by crushing.

Abstract: Apparatus of separating from each other the components of a mixture of water, oil and soil, such as sludge, which mixture is passed via a distribution and pacification chamber (7), which is connected to the supply pipe (2) and which has a large volume slowing down the speed of flow, into a separation chamber (3, 4, 5) where the flow of the mixture is first guided upwards in a laminar flow through a first bundle of plates (16) having vertical flow passages, the flow being reversed, while retaining laminar flow, directly after leaving the said first bundle of plates (16) and guided downwards through a second bundle of plates (17) having vertical flow passages which lead into a discharge chamber (33) having a throughflow cross-section increasing towards the discharge opening (34), where the separated components, water and soil, are discharged, while oil can be discharged in the reversing chamber (26) between the first (16) and second (17) bundle of plates.

Abstract: In a stabilized polyvinyl chloride molding mixture containing a stabilizer combination based upon alkali metal, alkaline earth metal, and/or zinc soaps, co-stabilizers, powdered, crystalline, hydrous aluminosilicate, and flow promoters, as well as optionally additional conventional additives, the improvement which comprises, per 100 parts by weight of polyvinyl chloride,(a) from about 0.2 to 5 parts by weight of a synthetic, crystalline, powdered alkali metal aluminosilicate containing from about 13 to 25 percent by weight of water of crystallization; and(b) from about 0.1 to 5 parts by weight of at least one co-stabilizer selected from the group consisting of .beta.-diketones, .alpha.-ketoenol esters, .alpha.-acyllactones, substituted 1,4-dihydropyridine-3,5-dicarboxylic acids, and pyrrole, the pyrrole being unsubstituted or substituted.

Abstract: Compounds of the formula ##STR1## wherein X, Y and Z are each independently hydrogen, halogen, lower alkyl, halo(lower alkyl), lower alkoxy, halo(lower alkoxy), (lower alkyl)thio or halo(lower alkyl)thio, orY and Z, together with each other, are lower alkylenedioxy;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as analgesics.

Abstract: The invention relates to an antibiotic polypeptide compound, or addition salt thereof, having a molecular weight no greater than 10000 and possessing bactericidal and bacteriolytic activities in respect of Gram-positive bacteria, the said compound comprising within the molecular structure thereof amino acid derivative units of formulae --NR--R.sub.1 --CO--, --NH--R.sub.2 --CO--, --NH--R.sub.3 --CO--, --NH--R.sub.4 --CO--, --NH--R.sub.5 --CO--, --NH--R.sub.6 --CO--, --NH--R.sub.7 --CO-- and ##STR1## wherein NH.sub.2 --R.sub.1 --COOH, NH.sub.2 --R.sub.2 --COOH, NH.sub.2 --R.sub.3 --COOH, NH.sub.2 --R.sub.4 --COOH, NH.sub.2 --R.sub.5 --COOH, NH.sub.2 --R.sub.6 --COOH and NH.sub.2 --R.sub.7 --COOH respectively represent isoleucine, phenylalanine, alanine, aspartic acid, glutamic acid, lysine and glycine and ##STR2## represents proline. The invention further provides a process for the preparation of antibiotic polypeptides by the aerobic culturing of a strain of S. epidermidis.

Abstract: This invention is directed to sanitary hygiene products. More particularly, this invention is directed to sanitary hygiene products for the absorption of secretions containing urine and/or blood which contains in an absorption layer an odor-preventing amount of one or more esters of citric acid and/or acetylcitric acid with aliphatic alcohols with from 1 to 6 carbon atoms or alicyclic alcohols with from 4 to 6 carbon atoms, as an odor-preventing substance.

Abstract: There are disclosed novel imidazole derivatives of the formula ##STR1## and derivatives of the formula ##STR2## the tautomers thereof, and non-toxic, pharmacologically acceptable addition salts thereof with inorganic or organic acids. The compounds described herein are useful in treating cardiac insufficiency.

Abstract: Compounds of the formula whereinHet is a heterocycle;n is an integer from 1 to 4, inclusive, preferably 2 or 3;R.sub.1 is H or acyl;R.sub.2 is H, R.sub.1 O, --NHSO.sub.2 R.sub.7, --NHCOR.sub.8, --NHCONHR.sub.8, --NH--CH.sub.2 --C.sub.6 H.sub.4 --R.sub.9, --CH.sub.2 OH, --CH.sub.2 SO.sub.2 R.sub.7, --CONHR.sub.8, halogen or --CN;R.sub.3 is H, halogen, R.sub.7 or --OR.sub.7 ; orR.sub.2 and R.sub.3, together with each other, are ##STR1## N.sub.4 is H, --CH.sub.3 or --C.sub.2 H.sub.5 ; R.sub.5 and R.sub.6 are each H or --CH.sub.3 ;R.sub.7 is C.sub.1 -C.sub.4 alkyl;R.sub.8 is H or C.sub.1 -C.sub.4 alkyl; andR.sub.9 is H, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy optionally interrupted by oxygen;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as bronchospasmolytics, spasmolytics, muscle-relaxants, antiallergics and hypotensives.

Abstract: Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or alkyl of 1 to 4 carbon atoms; andR.sub.2 is pyridyl, phenyl or mono-, di- or tri-substituted phenyl, where the substituents are alkyl of 1 to 2 carbon atoms, alkoxy of 1 to 2 carbon atoms, fluorine, chlorine, bromine, trifluoromethyl, nitro, benzyloxy or hydroxyl.The compounds are useful as nootropics.

Abstract: A selective coating for insulating glass, having high color neutrality, high solar transmissivity, a low K-value and great stability, consists of an electrically conductive layer in which very small, transparent, non-conductive particles are embedded.

Abstract: This invention relates to a pharmaceutical dosage unit composition consisting essentially of a gelatin capsule containing (1) a disintegrating core comprising clonidine, said disintegrating core having a readily water-soluble coating, and (2) a plurality of non-disintegrating cores comprising clonidine, said non-disintegrating cores having a coating consisting of from 20 to 90 percent by weight of a water-insoluble film former and from 10 to 80 percent by weight of a water-soluble polymer, the diameter of each of the disintegrating and non-disintegrating cores being at least about 5 mm.

Abstract: This invention is directed to a nail shielding device for use in applying a formaldehyde-containing liquid nail-hardening composition to human nails while protecting the cuticle and surrounding soft skin tissue from contact with said liquid compositions. The shielding device consists of an integral device having a forward end which is placed under the white tip of the nail, side and bottom portions which cover skin adjacent to the side edges of the nail and the bottom portion of the finger, a rear portion to cover the cuticle and skin to the rear of the cuticle, and two transverse apertures between the forward and rearward edges.

Abstract: Compounds of the formula ##STR1## wherein A is ##STR2## and R is hydrogen, alkyl of 1 to 5 carbon atoms, alkanoyl of 1 to 5 carbon atoms, alkenyl of 3 to 5 carbon atoms, (alkoxy of 1 to 4 carbon atoms)carbonyl, or aralkyl of 7 to 11 carbon atoms optionally halo-substituted,and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.

Abstract: This invention is directed to compositions of the developer-coupler type of the dyeing of hair consisting essentially of resorcinol derivatives or salts thereof as coupling components and, as developer components, the conventional components used in oxidation dyes.

Abstract: This invention relates to a process for preparing oligophosphonic or oligophosphinic acids or esters or salts thereof which comprises reacting an alkali metal ester of phosphorous acid or an alkali metal ester of arylphosphonous or alkylphosphonous acid with an olefin polyhalide and, optionally, saponifying the resultant product.

Abstract: Compounds of the formula ##STR1## wherein one of A and B is methenyl (--CH.dbd.) and the other is carbonyl; R.sub.1 is (alkyl of 1 to 3 carbon atoms)mercapto, (alkyl of 1 to 3 carbon atoms)sulfinyl or (alkyl of 1 to 3 carbon atoms)sulfonyl; andR.sub.2 is alkoxy of 1 to 3 carbon atoms;tautomers thereof, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds are useful as cardiotonics.

Abstract: The invention relates to novel substituted 5,11-dihydro-6H-dibenz[b,e]azepin-6-one of the formula ##STR1## wherein A represents a (1-methyl-4-piperidinyl)-acetyl, (4-methyl-1-piperazinyl)-acetyl, or [(1-methyl-4-piperidinyl)-amino]-carbonyl group,and the acid addition salts thereof, which have valuable pharmacological properties, particularly an ulcer-inhibiting and secretion-inhibiting activity. The compounds of Formula I may be prepared using methods conventionally used for analogous compounds.

Abstract: An aircraft propeller blade comprising an inner section which extends from the propeller hub toward the blade tip, a middle section adjacent to said inner section, and an outer section which extends from adjacent to said middle section to the blade tip; where the largest camber in the inner section decreases linearly over the blade length from adjacent to the propeller hub toward the blade tip, and the greatest camber height location shifts linearly over the blade length toward the blade tip; the largest camber in the middle section increases linearly over the blade length toward the blade tip, and the greatest camber height location shifts approximately linearly from adjacent to the inner section toward the blade tip; and the camber in the outer section decreases elliptically over the blade length toward the blade tip, and the greatest camber height location remains constant from adjacent to the middle section to the blade tip.

Abstract: This invention relates to a topical cosmetic preparation for treating oily hair or seborrhea which contains a sebosuppressively effective amount of at least one 4-aryl-4-oxo-but-2-enoic acid derivative.

Abstract: Compounds of the formula ##STR1## wherein R.sub.1 is phenylalkylamino, alkylamino, dialkylamino, piperidino, morpholino, thiomorpholino or 1-oxido-thiomorpholino;R.sub.2 is dialkylamino, piperidino, morpholino, thiomorpholino or 1-oxido-thiomorpholino; andR.sub.3 is halogen, alkoxy, alkylthio, phenylalkoxy or phenylalkylthio;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antithrombotics and antimetastatics.